Fact CheckerSign in

NCT07282392Recruiting

Helping Lupus Patients Manage Fibromyalgia Symptoms Through Emotional Awareness and Expression Therapy (EAET)

Evaluating the Feasibility and Efficacy of Emotional Awareness and Expression Therapy (EAET) on Fibromyalgia Outcomes in Patients With Systemic Lupus Erythematosus (SLE).

Source: ClinicalTrials.gov · Last updated 29 Dec 2025

Brief summary (registry, in English)

The goal of this clinical trial is to learn if a psychotherapy intervention works to relieve widespread pain in patients with lupus. The main questions it aims to answer are: Is the psychotherapy treatment safe for lupus patients? Are lupus patients able to complete the treatment? Can the treatment help improve chronic pain and other symptoms in lupus patients? Researchers will compare the treatment to a control (participants who will continue their medical treatment but will not receive psychotherapy for the time frame of the treatment) to see if the psychotherapy treatment works to relieve widespread pain and other lupus-related symptoms. Participants will: Fill out questionnaires before and after the treatment. Participate in 8 weekly treatment sessions, 2 hours per session, delivered via Zoom from their own home. Keep a list of medications and monitor any changes in their medication regimen.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
30 (estimated)
First submitted
2 Dec 2025
Start date
1 Dec 2025
Primary completion date
15 Oct 2028
Lead sponsor
University of Utah
Diseases
Lupus (SLE)
NCT number
NCT07282392

What you commit to

  • Study type: Interventional
  • Planned participants: 30
  • From 1 Dec 2025 to the primary completion date, 15 Oct 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Changes in medications in the past 3 months.

Other illness

  • Serious psychiatric disorders (e.g., schizophrenia or bipolar disorder) uncontrolled with medications.
  • Untreated alcohol or substance use disorder.
  • Substantial cognitive impairment.
  • Failure to complete the baseline assessments.

Other

  • Active suicidal ideation.
  • Enrollment in another treatment study.
  • Current involvement in health-related litigation or disability application.
  • Inability to use a computer and/or smartphone.
  • limited access to the internet.
  • Inability to communicate in English.

Who the study is looking for

  • Adults of all genders, ages 18-65.
  • A diagnosis of lupus and fibromyalgia or chronic widespread pain by a licensed rheumatologist
  • Be on a stable medication regimen.

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Utah
Coordinator of this site? Confirm its status
Salt Lake CityUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.